A COMPOSITION FOR PROMOTING GLP-1 SECRETION
An object of the present invention is to provide a composition having an effective GLP-1 secretion-promoting effect. The present invention attains this object by providing a composition for promoting GLP-1 secretion, comprising component (A) and component (B) as active ingredients, wherein said component (A) is a glycosyl naringenin and said component (B) is one or more selected from a group consisting of α-pinene, β-pinene, sabinene, camphene, valencene, β-caryophyllene, β-ionone, methyl anthranilate, methyl N-methylanthranilate, thymol, and nootkatone.
1 . A composition for promoting GLP-1 secretion, comprising component (A) and component (B) as active ingredients, wherein said component (A) is a glycosyl naringenin and said component (B) is one or more selected from a group consisting of α-pinene, β-pinene, sabinene, camphene, valencene, β-caryophyllene, β-ionone, methyl anthranilate, methyl N-methylanthranilate, thymol, and nootkatone.
2 . The composition for promoting GLP-1 secretion according to claim 1 , wherein said component (A) is 3″-α-monoglucosyl naringin.
3 . The composition for promoting GLP-1 secretion according to claim 1 , wherein said component (B) is thymol and/or nootkatone.
4 . The composition for promoting GLP-1 secretion according to claim 1 , comprising said component (A) and said component (B) at a molar ratio of 10,000:1 to 1:10.
5 . The composition for promoting GLP-1 secretion according to claim 1 , comprising said component (A) in an amount of 0.0001% by mass or more.
6 . The composition for promoting GLP-1 secretion according to claim 1 , which is for use in at least one of the followings: prevention or improvement of obesity, diabetes, and postprandial hyperglycemia; suppression of elevation of blood glucose level; inhibition of glucagon secretion; inhibition of gastric excretion and gastric acid secretion; suppression of appetite; suppression of food intake; and induction of satiety.
7 . A composition, comprising component (A) and component (B), wherein said component (A) is a glycosyl naringenin and said component (B) is one or more selected from a group consisting of α-pinene, β-pinene, sabinene, camphene, valencene, β-caryophyllene, β-ionone, methyl anthranilate, methyl N-methylanthranilate, thymol, and nootkatone.
8 . The composition according to claim 7 , comprising said component (A) and said component (B) at a molar ratio of 10,000:1 to 1:10.
9 . The composition according to claim 7 , wherein said component (A) is 3″-α-monoglucosyl naringin.
10 . The composition according to claim 7 , wherein said component (B) is thymol and/or nootkatone.
11 . The composition according to claim 7 , comprising said component (A) in an amount of 0.0001% by mass or more.
12 . A food or beverage, comprising the composition according to claim 1 .
13 . A supplement, comprising the composition according to claim 1 .
14 . A flavoring agent, comprising the composition according to claim 1 .
15 . A pharmaceutical or quasi-drug, comprising the composition according to claim 1 .
16 . A feed, comprising the composition according to claim 1 .
17 - 21 . (canceled)